API
< Back to all clusters
[HEALTH] · Germany, Austria · 2 sources

started · updated

Research explores gut microbiome role in pediatric arthritis and liver cancer

Recent medical studies are investigating the impact of the gut microbiome on autoimmune and oncological conditions.

A randomized, placebo-controlled trial involving 44 children with juvenile idiopathic arthritis (JIA) examined the effects of probiotic supplementation (VSL#3). The study found that while probiotics increased fecal TLR4 agonists, they did not improve disease activity, change microbiome diversity, or affect systemic cytokines. Researchers noted that probiotics may have a pro-inflammatory effect on the interaction between the microbiome and the immune system, suggesting that interventions targeting the microbiome in pediatric autoimmune diseases require careful consideration.

In a separate pilot study conducted by MedUni Wien, researchers investigated fecal microbiota transplantation (FMT) to overcome immunotherapy resistance in patients with advanced hepatocellular carcinoma (HCC). The phase-II study involved 12 patients who were resistant to standard treatments including Atezolizumab and Bevacizumab. Following a single FMT, 33% of participants achieved an objective tumor response, and 50% showed stable disease. While the study primarily focused on safety, the results suggest that modifying the gut microbiome could potentially open new treatment avenues for therapy-resistant liver cancer.

Entities

DGP · MedUni Wien